Skip to main content

Table 1 Main characteristics of the included studies

From: Prognostic factors for invasive mucinous adenocarcinoma of the lung: systematic review and meta-analysis

Study

Region

Study design

Sample

Follow-up (month)

Recruitment period

Survival endpoints

NOS

Data sources (R/C)

Gengpeng Lin (2018) [19]

China

Retrospective

26

NR

1999–2011

OS

7

R

Jian Wang (2022) [20]

China

Retrospective

98

Median 42

2013–2019

OS, DFS

8

R

Xiaoling Xu (2021) [21]

China

Retrospective

31

NR

2010–2015

OS

6

R

Takuya Matsui (2021) [22]

Japan

Retrospective

72

Median 63.3

2005–2015

OS, DFS

7

R

Daisuke Ueda (2021) [23]

Japan

Retrospective

47

Median 55

1997–2018

OS

8

R

Lei Cai (2021) [24]

China

Retrospective

51

NR

2010–2019

DFS

6

R

Tingting Wang (2021) [25]

China

Retrospective

317

Median 52.8

2011–2015

OS, DFS

8

R

Ho Yun Lee (2016) [26]

Korea

Retrospective

81

Median 33.7

2003–2011

OS, DFS

8

R

Tomonari Oki (2019) [27]

Japan

Retrospective

99

Median 55

2004–2017

OS

7

R

Hyun Jung Yoon (2022) [28]

Korea

Retrospective

121

Median 81.4

1998–2012

OS, DFS

7

R

Min A. Lee (2020) [29]

Korea

Retrospective

119

Median 89.3

1998–2012

OS

7

R

  1. Abbreviations: OS overall survival, DFS disease-free survival, NR not reported, R reported, C calculated, NOS Newcastle–Ottawa Quality Assessment Scale